INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 435m ago
HOUSE PTR34m ago
SEC 13F34m ago
ROBINHOOD CHAIN34m ago
Corporate insider
TB

Tressler Nick B.

Chief Financial OfficerCIK 0001794362

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score15
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
TB
Tressler Nick B.Chief Financial Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A—
75.0K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Vistagen Therapeutics, Inc.Chief Financial Officer · Dec 4, 2025
15
TB
Tressler Nick B.Chief Financial Officer
VTGNVistagen Therapeutics, Inc.
Grant or award
A
—
150.0K sh
Dec 1, 2025
Dec 4, 2025
traded Dec 1, 2025
+3d
SEC FORM 4

Evidence